Change search
ReferencesLink to record
Permanent link

Direct link
Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.
Show others and affiliations
2004 (English)In: Haematologica, ISSN 1592-8721, Vol. 89, no 5, 520-7 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2004. Vol. 89, no 5, 520-7 p.
Keyword [en]
Adult, Aged, Chronic Disease, Diarrhea/chemically induced, Dose-Response Relationship; Drug, Female, Headache/chemically induced, Heart Rate/drug effects, Humans, Male, Middle Aged, Myeloproliferative Disorders/*complications, Nausea/chemically induced, Patient Compliance, Patient Dropouts, Platelet Aggregation Inhibitors/*adverse effects/*therapeutic use, Prospective Studies, Quinazolines/*adverse effects/*therapeutic use, Thrombocytosis/*drug therapy/etiology
National Category
URN: urn:nbn:se:umu:diva-12918PubMedID: 15136214OAI: diva2:152589
Available from: 2007-04-24 Created: 2007-04-24 Last updated: 2016-08-19Bibliographically approved

Open Access in DiVA

No full text

Other links


Search in DiVA

By author/editor
Markevärn, Berit
By organisation

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 51 hits
ReferencesLink to record
Permanent link

Direct link